Literature DB >> 1559407

Molecular physiology and genetics of NIDDM. Importance of metabolic staging.

D K Granner1, R M O'Brien.   

Abstract

Insulin resistance and beta-cell failure account for the complex clinical presentation of non-insulin-dependent diabetes mellitus (NIDDM). Insulin resistance primarily involves defective regulation of hepatic glucose production and the peripheral utilization of glucose. Considerable progress has been made in understanding the basic molecular biology, biochemistry, and physiology of these processes. Similarly, the mechanisms involved in insulin synthesis, processing, storage, and secretion are being elucidated. The relative contributions of insulin resistance and beta-cell failure are difficult to evaluate when the disease is fully established and clinically apparent but may be more obvious early, i.e., in people with impaired glucose tolerance or individuals at risk for developing the disease. The latter can be identified because there is a strong genetic determinant for NIDDM; the offspring of two diabetic parents have a markedly increased incidence of the disease. In addition to genetic factors, environmental components contribute to the multifactorial etiology of NIDDM. Efforts to establish the importance of these different factors will be assisted if a metabolic staging of NIDDM can be agreed on. This staging, which should correlate the pathophysiological events responsible for the transition from normal glucose tolerance to frank NIDDM with clinical status, would be based on what is known about insulin resistance and beta-cell function. Staging will also provide for a classification of the number of causes that lead to NIDDM, if indeed, there is more than one cause of the general phenotype. Strategies for defining the gene or genes responsible for NIDDM can be subsequently devised based on the temporal sequence of appearance of pathophysiological defects and what is known about the molecular biology of insulin action. Understanding the defective metabolic code that results in NIDDM will require the concerted efforts of investigators from various disciplines. This is used throughout the text to avoid confusion with those people who have impaired glucose tolerance but not NIDDM.

Entities:  

Mesh:

Year:  1992        PMID: 1559407     DOI: 10.2337/diacare.15.3.369

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  25 in total

1.  Thematic minireview series: a perspective on the biology of phosphoenolpyruvate carboxykinase 55 years after its discovery.

Authors:  Richard W Hanson
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

Review 2.  Gene expression as a target for new drug discovery.

Authors:  A Heguy; A A Stewart; J D Haley; D E Smith; J G Foulkes
Journal:  Gene Expr       Date:  1995

3.  A novel (TA)n polymorphism in the hexokinase II gene: application to noninsulin-dependent diabetes mellitus in the Pima Indians.

Authors:  H Ardehali; G E Tiller; R L Printz; H Mochizuki; M Prochazka; D K Granner
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

Review 4.  Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus.

Authors:  H Beck-Nielsen; L C Groop
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

5.  Clinical and biochemical manifestations of syndrome X in obese children.

Authors:  Efimia Papadopoulou-Alataki; Kiriaki Papadopoulou-Legbelou; Loukas Doukas; Kiparissia Karatzidou; Aikaterini Pavlitou-Tsiontsi; Emmanouil Pagkalos
Journal:  Eur J Pediatr       Date:  2004-10       Impact factor: 3.183

6.  Insulin receptor substrate-1 variants in non-insulin-dependent diabetes.

Authors:  M Laakso; M Malkki; P Kekäläinen; J Kuusisto; S S Deeb
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

7.  Hyperinsulinemia is associated with altered insulin receptor mRNA splicing in muscle of the spontaneously obese diabetic rhesus monkey.

Authors:  Z Huang; N L Bodkin; H K Ortmeyer; B C Hansen; A R Shuldiner
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

8.  The carnivore connection: dietary carbohydrate in the evolution of NIDDM.

Authors:  J C Miller; S Colagiuri
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

9.  Hepatocyte nuclear factor-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse glucose-6-phosphatase gene transcription.

Authors:  R S Streeper; E M Eaton; D H Ebert; S C Chapman; C A Svitek; R M O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1.

Authors:  X J Sun; D L Crimmins; M G Myers; M Miralpeix; M F White
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.